Literature DB >> 25783211

When do performance-based risk-sharing arrangements make sense?

Michael Drummond1.   

Abstract

Mesh：

Year:  2015        PMID： 25783211     DOI： 10.1007/s10198-015-0683-z

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN： 1618-7598


× No keyword cloud information.
  8 in total

1.  Multiple sclerosis risk sharing scheme: a costly failure.

Authors:  James Raftery
Journal:  BMJ       Date:  2010-06-03

2.  Establishing a comprehensive continuum from an evidentiary base to policy development for health technologies: the Ontario experience.

Authors:  Leslie Levin; Ron Goeree; Nancy Sikich; Birthe Jorgensen; Melissa C Brouwers; Tony Easty; Catherine Zahn
Journal:  Int J Technol Assess Health Care       Date:  2007       Impact factor: 2.188

3.  Coverage with evidence development: an examination of conceptual and policy issues.

Authors:  John Hutton; Paul Trueman; Christopher Henshall
Journal:  Int J Technol Assess Health Care       Date:  2007       Impact factor: 2.188

4.  Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task force.

Authors:  Louis P Garrison; Adrian Towse; Andrew Briggs; Gerard de Pouvourville; Jens Grueger; Penny E Mohr; J L Hans Severens; Paolo Siviero; Miguel Sleeper
Journal:  Value Health       Date:  2013-07-19       Impact factor: 5.725

5.  Where are we on "risk-sharing" agreements?

Authors:  Peter J Neumann
Journal:  Value Health       Date:  2013-06-14       Impact factor: 5.725

Review 6.  Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.

Authors:  Jakub Adamski; Brian Godman; Gabriella Ofierska-Sujkowska; Bogusława Osińska; Harald Herholz; Kamila Wendykowska; Ott Laius; Saira Jan; Catherine Sermet; Corrine Zara; Marija Kalaba; Roland Gustafsson; Kristina Garuolienè; Alan Haycox; Silvio Garattini; Lars L Gustafsson
Journal:  BMC Health Serv Res       Date:  2010-06-07       Impact factor: 2.655

7.  Sharing risk between payer and provider by leasing health technologies: an affordable and effective reimbursement strategy for innovative technologies?

Authors:  Richard Edlin; Peter Hall; Klemens Wallner; Christopher McCabe
Journal:  Value Health       Date:  2014-04-29       Impact factor: 5.725

Review 8.  Validation of surrogate endpoints in advanced solid tumors: systematic review of statistical methods, results, and implications for policy makers.

Authors:  Oriana Ciani; Sarah Davis; Paul Tappenden; Ruth Garside; Ken Stein; Anna Cantrell; Everardo D Saad; Marc Buyse; Rod S Taylor
Journal:  Int J Technol Assess Health Care       Date:  2014-07       Impact factor: 2.188
  8 in total
  4 in total

Review 1.  Performance-Based Risk-Sharing Arrangements: An Updated International Review.

Authors:  Josh J Carlson; Shuxian Chen; Louis P Garrison
Journal:  Pharmacoeconomics       Date:  2017-10       Impact factor: 4.981

2.  Incentivizing research into the effectiveness of medical devices.

Authors:  Michael Drummond; Rosanna Tarricone; Aleksandra Torbica
Journal:  Eur J Health Econ       Date:  2016-12

3.  The economics of alternative payment models for pharmaceuticals.

Authors:  Jakub P Hlávka; Jeffrey C Yu; Dana P Goldman; Darius N Lakdawalla
Journal:  Eur J Health Econ       Date:  2021-03-16

4.  Coverage with evidence development for medical devices in Europe: Can practice meet theory?

Authors:  Michael Drummond; Carlo Federici; Vivian Reckers-Droog; Aleksandra Torbica; Carl Rudolf Blankart; Oriana Ciani; Zoltán Kaló; Sándor Kovács; Werner Brouwer
Journal:  Health Econ       Date:  2022-02-26       Impact factor: 2.395
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.